03/14/2019
Alberta Innovates, the Alberta Cancer Foundation and DynaLIFE have partnered to fund $1.2 million for this next stage of evaluation for Syantra, the University of Calgary spin-off company that created a non-invasive blood test and is developing it for commercialization within the next two years. Syantra has partnered with the UCalgary for the Calgary arm of the clinical study.
Last year Alberta Innovates, the Alberta Cancer Foundation and DynaLIFE joined together to help commercialize Alberta-owned innovations that will detect cancer earlier and improve treatment for Albertans. The $2.5 million challenge is part of Alberta Innovates’ Alberta Small Business Innovation and Research Initiative (ASBIRI) program.
"The key to a sustainable health system is the courage to embrace constant change and improvement. Finding and implementing new health innovation is a challenge for all Albertans. DynaLIFE is very pleased to support research across our province like Syantra in Calgary who are looking to change the future of Breast Cancer Detection and Treatment. We are proud partners of the Alberta Cancer Foundation, Alberta Innovates, and Syantra in the goal of delivering this research to Albertans. As a private sector partner we can leverage our skills and resources with those of our public partners to rapidly bring innovation from the bench to the bedside."
- Jason Pincock CEO, DynaLIFE
https://albertainnovates.ca/calgary-made-blood-test-could-revolutionize-breast-cancer-treatment/
Calgary-made blood test set to revolutionize breast cancer treatmentMar 14, 2019 CALGARY – Detecting cancer as early as possible is important to achieving the best possible treatment success. This year, more than 1000 women in Calgary will undergo a liquid (blood) biopsy this year, alongside their...